BIOLIFE SOLUTIONS INC (BLFS) Stock Price & Overview
NASDAQ:BLFS • US09062W2044
The current stock price of BLFS is 18.215 USD. Today BLFS is down by -4.18%. In the past month the price decreased by -16.07%. In the past year, price decreased by -23.96%.
BLFS Key Statistics
- Market Cap
- 879.785M
- P/E
- 86.74
- Fwd P/E
- 121.76
- EPS (TTM)
- 0.21
- Dividend Yield
- N/A
BLFS Stock Performance
BLFS Stock Chart
BLFS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BLFS. When comparing the yearly performance of all stocks, BLFS is a bad performer in the overall market: 85.97% of all stocks are doing better.
BLFS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BLFS. No worries on liquidiy or solvency for BLFS as it has an excellent financial health rating, but there are worries on the profitability.
BLFS Earnings
On February 26, 2026 BLFS reported an EPS of 0.22 and a revenue of 24.76M. The company beat EPS expectations (1095.32% surprise) and beat revenue expectations (0.81% surprise).
BLFS Forecast & Estimates
16 analysts have analysed BLFS and the average price target is 32.87 USD. This implies a price increase of 80.44% is expected in the next year compared to the current price of 18.215.
For the next year, analysts expect an EPS growth of -28.76% and a revenue growth 17.71% for BLFS
BLFS Groups
Sector & Classification
BLFS Financial Highlights
Over the last trailing twelve months BLFS reported a non-GAAP Earnings per Share(EPS) of 0.21. The EPS increased by 141.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.13% | ||
| ROE | -1.24% | ||
| Debt/Equity | 0 |
BLFS Ownership
BLFS Latest News, Press Relases and Analysis
BLFS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.26 | 184.15B | ||
| DHR | DANAHER CORP | 22.17 | 137.935B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.72 | 44.512B | ||
| A | AGILENT TECHNOLOGIES INC | 16.77 | 32.629B | ||
| WAT | WATERS CORP | 19.9 | 29.189B | ||
| IQV | IQVIA HOLDINGS INC | 12.92 | 28.803B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.17 | 24.984B | ||
| ILMN | ILLUMINA INC | 22.63 | 18.577B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.21 | 17.159B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.22 | 13.558B | ||
| RVTY | REVVITY INC | 15.64 | 10.021B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.418B | ||
| TECH | BIO-TECHNE CORP | 23.06 | 8.389B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BLFS
Company Profile
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 155 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Company Info
IPO: 1989-11-22
BIOLIFE SOLUTIONS INC
Suite 310, 3303 Monte Villa Parkway
Bothell WASHINGTON 98021 US
CEO: Michael Rice
Employees: 155
Phone: 14254011400
BIOLIFE SOLUTIONS INC / BLFS FAQ
What does BIOLIFE SOLUTIONS INC do?
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 155 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Can you provide the latest stock price for BIOLIFE SOLUTIONS INC?
The current stock price of BLFS is 18.215 USD. The price decreased by -4.18% in the last trading session.
What is the dividend status of BIOLIFE SOLUTIONS INC?
BLFS does not pay a dividend.
What is the ChartMill rating of BIOLIFE SOLUTIONS INC stock?
BLFS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does BIOLIFE SOLUTIONS INC belong to?
BIOLIFE SOLUTIONS INC (BLFS) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Should I buy BLFS stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BLFS.
What is the employee count for BLFS stock?
BIOLIFE SOLUTIONS INC (BLFS) currently has 155 employees.